NCT06216223

Brief Summary

This is a randomized comparative clinical trial carried out to compare between laser ablation and surgery in treating anal diseases in inflammatory bowel diseases patients and find out if one is superior to the other. Inflammatory bowel diseases patients with anal problems were divided into 2 groups, one group had traditional surgery and the other had laser ablation for anal diseases and results were compared between the 2 groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2024

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

7 months

First QC Date

December 27, 2023

Last Update Submit

May 12, 2024

Conditions

Keywords

anal fissurehemorrhoidsinflammatory bowel diseasecrohn's diseaseulcerative colitis

Outcome Measures

Primary Outcomes (11)

  • Operation time

    operation time in minutes was studied between the 2 groups

    Intraoperative (from skin incision to wound dressing.)

  • operative bleeding

    bleeding in cc was calculated between the 2 groups

    Intraoperative to 2 weeks after operation.

  • post operative anal discharge

    presence of post operative anal discharge was detected in the 2 groups

    from incision to 2 weeks after operation.

  • pain score with visual analogue scale

    pain score with visual analogue scale was studied between the 2 groups,minimum score is 0 which means painless and maximum score is 10 which means very painful

    from the 1st day to 2 weeks postoperatively

  • Healing time

    time for complete healing after operation was studied between the 2 groups

    healing time was studies from the 1st day to 3 months after operation

  • Return to work

    Return to work after operation was studied between the 2 groups

    Return to work was assessed from one day to 2 months after surgery

  • patient satisfaction score

    patient satisfaction score among patients in the 2 groups was studied using customer satisfaction score, minimum score is 1 means very dissatisfied and maximum score is 10 means very satisfied

    from one day to 3 months after operation

  • Recurrence

    recurrence between 2 groups was assessed

    detection of recurrence from 3 to 6 months after operation

  • Fistula occurence

    fistula occurence studied between the 2 groups

    from 2 weeks to 2 months after operation

  • Stenosis

    post operative stenosis between the 2 groups was studied

    stenosis was detected from wound healing to 6 months later

  • Discharge from hospital

    hospital stay studied between the 2 groups

    from one day post operative to one week

Secondary Outcomes (3)

  • age

    age of participants was recorded for one year duration of the study

  • sex

    sex of participants was recorded for one year duration of the study

  • specific disease

    diagnosis of diseases known 2 days before surgery from history

Study Arms (2)

laser

ACTIVE COMPARATOR

laser ablation of anal diseases in inflammatory bowel patients

Procedure: treatment of anal diseases in inflammatory bowel patientsDevice: Laser

traditional surgery

SHAM COMPARATOR

traditional surgery for anal diseases in inflammatory bowel patients

Procedure: treatment of anal diseases in inflammatory bowel patientsProcedure: traditional surgery

Interventions

treatment of anal diseases in inflammatory bowel patients

lasertraditional surgery
LaserDEVICE

laser

laser

traditional surgery

traditional surgery

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with history of inflammatory bowel disease ( non specific colitis, crohn's disease, ulcerative colitis).
  • Patients who accidently discovered to have inflammatory bowel disease.
  • Age group between 18 to 60 years old

You may not qualify if:

  • Informed consent refusal.
  • Proved malignancy in inflammatory bowel disease patients
  • Patients less than 18 years old or more than 60 years old
  • Contraindications to general and spinal anesthesia
  • other types of colitis as ischemic colitis, pseudo-membranous colitis, infective colitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagazig University Hospitals

Zagazig, 44519, Egypt

Location

Related Publications (1)

  • Zakaria R, Amin MM, Abo-Alella HA, Hegab YH. Laser hemorrhoidoplasty versus hemorrhoidectomy in the treatment of surgically indicated hemorrhoids in inflammatory bowel patients: a randomized comparative clinical study. Surg Endosc. 2025 Jan;39(1):249-258. doi: 10.1007/s00464-024-11351-3. Epub 2024 Nov 7.

MeSH Terms

Conditions

Inflammatory Bowel DiseasesFissure in AnoHemorrhoidsCrohn DiseaseColitis, Ulcerative

Interventions

Lasers

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesAnus DiseasesRectal DiseasesVascular DiseasesCardiovascular DiseasesColitisColonic Diseases

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Reham Zakaria, PhD

    faculty of medicine Zagazig University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 27, 2023

First Posted

January 22, 2024

Study Start

September 5, 2023

Primary Completion

April 5, 2024

Study Completion

April 5, 2024

Last Updated

May 14, 2024

Record last verified: 2024-05

Locations